AHA Coding Clinic® for ICD-9 - 2010 Issue 2; Ask the Editor
Encounter for Neulasta Injection
A patient is receiving ongoing chemotherapy for stage III non-small-cell lung carcinoma. The current encounter is for Neulasta injection to prevent infection. The patient received 6 milligrams of Neulasta subcutaneously. What is/are the correct diagnosis and procedure code(s) for the encounter? ...
Subscribe or sign in to view the full article.
Article Overview
This premium coding article explains how to approach an encounter related to Neulasta administration during active cancer treatment. It is aimed at coding professionals who need to understand the diagnosis and procedure coding context for prophylactic therapy, chemotherapy-related care, and related clinical documentation. The article presents the relevant diagnosis and procedure coding guidance for this type of encounter without requiring the reader to interpret the underlying case on their own.
Why This Topic Matters
Encounters for supportive oncology medications are common and can affect both diagnosis sequencing and procedure code selection. Understanding how this type of visit is coded helps support accurate reporting for chemotherapy-related care and associated preventive treatment.
What You Will Learn
- How the encounter is classified in the context of supportive care during cancer treatment
- How the article frames the diagnosis coding context for an encounter involving prophylactic treatment
- How the article addresses procedure coding for medication administration in this clinical setting
- What general coding categories are involved in a Neulasta-related encounter
Who Should Read This
- Medical coders
- Coding auditors
- Revenue cycle staff
- Clinical documentation specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com